ProbiSearch SL   Report issue

For profit
Founded: Tres Cantos Spain (2011)

Organization Overview

First Clinical Trial
2014
NCT02215304
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ProbiSearch SL

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 6
  • # of Trial APIs: 8